Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feliu

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Chemotherapy|March 31, 2011
Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational studyJ Feliu Batlle, E Cuadrado, J Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapyJ Feliu, J Calvilio, A Escribano, et al.
American Journal of Clinical Oncology|February 1, 1992
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten yearsM Gonzalez Baron, C Garcia Giron, P Zamora, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2006
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancerJ Feliu, G Martín, J Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative GroupM González Barón, J Feliu, E Espinosa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Internet use by cancer patients: should oncologists 'prescribe' accurate web sites in combination with chemotherapy? A survey in a Spanish cohortM López-Gómez, C Ortega, I Suárez, et al.
American Journal of Clinical Oncology|April 1, 1996
Cisplatin and UFT modulated with leucovorin for the treatment of Advanced non-small-cell lung cancerJ Feliu, M Gonzalez-Baron, E Espinosa, et al.
British Journal of Cancer|October 27, 2004
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancerJ Feliu, J M Vicent, C García-Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 12, 2020
Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?A Gallego, J Ramon-Patino, J Brenes, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancerJ Feliu, A Artal, M González Barón, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Chemotherapy|March 31, 2011
Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: a retrospective observational studyJ Feliu Batlle, E Cuadrado, J Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapyJ Feliu, J Calvilio, A Escribano, et al.
American Journal of Clinical Oncology|February 1, 1992
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten yearsM Gonzalez Baron, C Garcia Giron, P Zamora, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2006
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancerJ Feliu, G Martín, J Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative GroupM González Barón, J Feliu, E Espinosa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Internet use by cancer patients: should oncologists 'prescribe' accurate web sites in combination with chemotherapy? A survey in a Spanish cohortM López-Gómez, C Ortega, I Suárez, et al.
American Journal of Clinical Oncology|April 1, 1996
Cisplatin and UFT modulated with leucovorin for the treatment of Advanced non-small-cell lung cancerJ Feliu, M Gonzalez-Baron, E Espinosa, et al.
British Journal of Cancer|October 27, 2004
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancerJ Feliu, J M Vicent, C García-Girón, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 12, 2020
Bevacizumab in recurrent ovarian cancer: could it be particularly effective in patients with clear cell carcinoma?A Gallego, J Ramon-Patino, J Brenes, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancerJ Feliu, A Artal, M González Barón, et al.
Pageof 15